2020
DOI: 10.1038/s41374-019-0335-5
|View full text |Cite
|
Sign up to set email alerts
|

Temperature elevation in epileptogenic foci exacerbates epileptic discharge through TRPV4 activation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
21
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 25 publications
(21 citation statements)
references
References 48 publications
0
21
0
Order By: Relevance
“…Indeed, TRPV4 may contribute to disease progression of epilepsy [59]. Epileptogenic foci possess elevated temperatures compared to healthy brain regions, and this activates TRPV4 channels.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Indeed, TRPV4 may contribute to disease progression of epilepsy [59]. Epileptogenic foci possess elevated temperatures compared to healthy brain regions, and this activates TRPV4 channels.…”
Section: Discussionmentioning
confidence: 99%
“…This was illustrated by wild type mice having greater epileptic EEG activity than TRPV4 knockout mice [59].…”
Section: Discussionmentioning
confidence: 99%
“…It has been shown that 0.2° to 2°C changes in brain temperature significantly affect brain functions and neuronal properties ( 8 ). Furthermore, we found that 1°C hyperthermia could exacerbate epilepsy in vivo through the TRPV4 overactivation ( 26 ). Thus, we speculate that such a seemingly small temperature change increases TRPV4 activity and affects physiological responses in vivo.…”
Section: Discussionmentioning
confidence: 99%
“…2018), brain (Shibasaki et al . 2020) and the urinary bladder, has been reported. With significant changes in bladder functions noted in TRPV4 deficient mice (Gevaert et al .…”
Section: Introductionmentioning
confidence: 99%
“…arachidonic acid metabolites such as 5,6-epoxyeicosatrienoic acid) stimuli (Garcia-Elias et al 2014). Distribution of TRPV4 in various tissues, such as airway (Palaniyandi et al 2020), heart (Adapala et al 2020), skin (Szabo et al 2019), intestine (Huang et al 2018), brain (Shibasaki et al 2020) and the urinary bladder, has been reported. With significant changes in bladder functions noted in TRPV4 deficient mice (Gevaert et al 2007), there has been a growing interest in TRPV4 as a therapeutic target for bladder dysfunctions.…”
Section: Introductionmentioning
confidence: 99%